Recent advances in the genetic analysis of PTEN and PI3K innate immune properties

Immunobiology

Volumn 213, Issue 9-10, 2008, Pages 759-765

  Günzl, Philipp ^a   Schabbauer, Gernot ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Innate immunity; PI3K; PTEN; TLR

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TOLL LIKE RECEPTOR;

CANCER CELL; CARCINOGENESIS; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN; IMMUNOBIOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MALIGNANT TRANSFORMATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; HUMANS; IMMUNITY, INNATE; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 52749098868     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.07.028     Document Type: Review

References (37)

1. Aksoy E., Vanden B.W., Detienne S., Amraoui Z., Fitzgerald K.A., Haegeman G., Goldman M., and Willems F. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of toll-like receptor 3 and 4. Eur. J. Immunol. 35 (2005) 2200-2209
2. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., Godowski P.J., Ulevitch R.J., and Knaus U.G. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 1 (2000) 533-540
3. Az-Guerra M.J., Castrillo A., Martin-Sanz P., and Bosca L. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J. Immunol. 162 (1999) 6184-6190
4. Brachmann S.M., Yballe C.M., Innocenti M., Deane J.A., Fruman D.A., Thomas S.M., and Cantley L.C. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Mol. Cell. Biol. 25 (2005) 2593-2606
5. Burgering B.M., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995) 599-602
6. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
7. Cao X., Wei G., Fang H., Guo J., Weinstein M., Marsh C.B., Ostrowski M.C., and Tridandapani S. The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports toll-like receptor 4 signaling in murine peritoneal macrophages. J. Immunol. 172 (2004) 4851-4857
8. Frame S., and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359 (2001) 1-16
9. Fruman D.A., Mauvais-Jarvis F., Pollard D.A., Yballe C.M., Brazil D., Bronson R.T., Kahn C.R., and Cantley L.C. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat. Genet. 26 (2000) 379-382
10. Fukao T., and Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 24 (2003) 358-363
11. Fukao T., Tanabe M., Terauchi Y., Ota T., Matsuda S., Asano T., Kadowaki T., Takeuchi T., and Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3 (2002) 875-881
12. Fukao T., Yamada T., Tanabe M., Terauchi Y., Ota T., Takayama T., Asano T., Takeuchi T., Kadowaki T., Hata J.J., and Koyasu S. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 3 (2002) 295-304
13. Georgel P., Jiang Z., Kunz S., Janssen E., Mols J., Hoebe K., Bahram S., Oldstone M.B., and Beutler B. Vesicular stomatitis virus glycoprotein G activates a specific antiviral toll-like receptor 4-dependent pathway. Virology 362 (2007) 304-313
14. Gericke A., Munson M., and Ross A.H. Regulation of the PTEN phosphatase. Gene 374 (2006) 1-9
15. Guha M., and Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277 (2002) 32124-32132
16. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo L., Sozzani S., Mantovani A., Altruda F., and Wymann M.P. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287 (2000) 1049-1053
17. Kim Y.H., Choi K.H., Park J.W., and Kwon T.K. LY294002 inhibits LPS-induced NO production through a inhibition of NF-kappaB activation: independent mechanism of phosphatidylinositol 3-kinase. Immunol. Lett. 99 (2005) 45-50
18. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
19. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A.V., and Wu D. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287 (2000) 1046-1049
20. Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., and Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16 (1997) 64-67
21. Luyendyk J.P., Schabbauer G.A., Tencati M., Holscher T., Pawlinski R., and Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J. Immunol. 180 (2008) 4218-4226
22. Marsh D.J., Dahia P.L., Zheng Z., Liaw D., Parsons R., Gorlin R.J., and Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16 (1997) 333-334
23. Martin M., Rehani K., Jope R.S., and Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6 (2005) 777-784
24. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., and Hallman M. Phosphatidylinositol 3-kinase is involved in toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33 (2003) 597-605
25. Rhee S.H., Kim H., Moyer M.P., and Pothoulakis C. Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells. J. Biol. Chem. 281 (2006) 18560-18568
26. Sasaki T., Irie-Sasaki J., Jones R.G., Oliveira-dos-Santos A.J., Stanford W.L., Bolon B., Wakeham A., Itie A., Bouchard D., Kozieradzki I., Joza N., Mak T.W., Ohashi P.S., Suzuki A., and Penninger J.M. Function of PI3Kgamma in thymocyte development, T-cell activation, and neutrophil migration. Science 287 (2000) 1040-1046
27. Schabbauer G., Tencati M., Pedersen B., Pawlinski R., and Mackman N. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1963-1969
28. Schabbauer G., Luyendyk J., Crozat K., Jiang Z., Mackman N., Bahram S., and Georgel P. TLR4/CD14-mediated PI3K activation is an essential component of interferon-dependent VSV resistance in macrophages. Mol. Immunol (2008)
29. Sly L.M., Rauh M.J., Kalesnikoff J., Song C.H., and Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21 (2004) 227-239
30. Staal S.P. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. USA 84 (1987) 5034-5037
31. Suzuki A., de la Pompa J.L., Stambolic V., Elia A.J., Sasaki T., del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W., Fukumoto M., and Mak T.W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8 (1998) 1169-1178
32. Suzuki A., Nakano T., Mak T.W., and Sasaki T. Portrait of PTEN: messages from mutant mice. Cancer Sci. 99 (2008) 209-213
33. Terauchi Y., Tsuji Y., Satoh S., Minoura H., Murakami K., Okuno A., Inukai K., Asano T., Kaburagi Y., Ueki K., Nakajima H., Hanafusa T., Matsuzawa Y., Sekihara H., Yin Y., Barrett J.C., Oda H., Ishikawa T., Akanuma Y., Komuro I., Suzuki M., Yamamura K., Kodama T., Suzuki H., Yamamura K., Kodama T., Suzuki H., Koyasu S., Aizawa S., Tobe K., Fukui Y., Yazaki Y., and Kadowaki T. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat. Genet. 21 (1999) 230-235
34. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., and Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
35. Williams D.L., Li C., Ha T., Ozment-Skelton T., Kalbfleisch J.H., Preiszner J., Brooks L., Breuel K., and Schweitzer J.B. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J. Immunol. 172 (2004) 449-456
36. Yu Y., Nagai S., Wu H., Neish A.S., Koyasu S., and Gewirtz A.T. TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression. J. Immunol. 176 (2006) 6194-6201
37. Zhang W.J., Wei H., Hagen T., and Frei B. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc. Natl. Acad. Sci. USA 104 (2007) 4077-4082